1332 Anti-CD161 antibody IMT-009 is a novel immunotherapeutic agent that reinvigorates T and NK cell function and anti-tumor efficacy through blocking interaction of CD161 with its ligand CLEC2D

Alexandria Fusco,Elizabeth Scanlon, Frano Irvine,Flavian Brown, Jeffrey Colbert, Andy Tu, Stephanie Gaerlan, Kelly Nichols, Teresse de Rham,Matthew Huggins, Kendall Dionne, Ming Tang, Heather Flick, Alison Tisdale,Seng-Lai Tan,Shruti Malu

Regular and Young Investigator Award Abstracts(2022)

引用 0|浏览0
暂无评分
关键词
novel immunotherapeutic agent,nk cell function,ligand,anti-tumor
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要